BriaCell Therapeutics Corp. Warrant expiring 2030 Stock Performance

Open $0.28	Prev. Close N/A	Circuit Range N/A
Day Range $0.28 - $0.28	Year Range $0.08 - $0.49	Volume 2,100
Average Traded $0.28

BriaCell Therapeutics Corp. Warrant expiring 2030 Share Price Chart

$0.28$0.28

BriaCell Therapeutics Corp. Warrant expiring 2030 Stock Fundamentals & Key Indicators

Market Cap $122703.06	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) N/A	Revenue (TTM) $0.00	Return On Equity (TTM) -127.51%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY 11.50%

BriaCell Therapeutics Corp. Warrant expiring 2030 Quarterly Profit & Loss

All figures in USD

Particulars	Jul 2025	Oct 2025	Jan 2026	Apr 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$8.09	-$8.20	-$7.22	-$7.16
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-1.36%	11.95%	0.83%

BriaCell Therapeutics Corp. Warrant expiring 2030 Annual Profit & Loss

All figures in USD

Particulars	2025
Revenue	$0.00
Net Profit	-$26.31
Net Profit Margin	N/A
Income Change	N/A

About BriaCell Therapeutics Corp. Warrant expiring 2030

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

BriaCell Therapeutics Corp. Warrant expiring 2030 Historical Returns

Month	Open	Close	Change %
Oct 2026	$0.28	$0.28	+47.37%
Sep 2026	$0.19	$0.19	+126.19%
Aug 2026	$0.08	$0.08	-6.67%
Jul 2026	$0.10	$0.09	+12.50%
Jun 2026	$0.08	$0.08	-11.11%
Apr 2026	$0.15	$0.09	-21.05%
Mar 2026	$0.16	$0.11	-25.49%
Feb 2026	$0.14	$0.15	-10.00%
Jan 2026	$0.28	$0.17	-37.04%
Dec 2025	$0.42	$0.27	-16.41%
Nov 2025	$0.36	$0.32	-22.54%
Oct 2025	$0.34	$0.42	+26.36%

BCTXZ Share Price FAQs

What is BriaCell Therapeutics Corp. Warrant expiring 2030 share price today?

BriaCell Therapeutics Corp. Warrant expiring 2030 share price today is $0.29 as on October 3, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BriaCell Therapeutics Corp. Warrant expiring 2030 stock?

The 52 week high of BriaCell Therapeutics Corp. Warrant expiring 2030 stock is $0.49, while the 52 week low is $0.08 as of 3 Oct '26.

What is BCTXZ's market capitalisation today?

BCTXZ market capitalisation is $122703.06 as of October 11, 2026, at 12:25 am IST.

What is BCTXZ's net income for the last quarter?

BCTXZ's net income for the last quarter is -7.16B USD.

What is the 5 year returns of BCTXZ?

The 5 year returns of BCTXZ is -73.64% as on 3 Oct '26.

What is the high & low stock price of BCTXZ today?

BCTXZ stock price hit a high of $0.28 and low of $0.28 as of 3 Oct '26.

Can I buy BCTXZ shares in India?

Yes. You can buy BCTXZ in India by opening an international trading account.